Abstract:BACKGROUND:To investigate the protective efficacy of miR-155 on down regulating NADPH oxidase isoform subunit A1 (NoxA1) gene expression, resulting in inhibition of VSMC migration and over proliferation and thus ameliorating the progression of arterial atherosclerosis in AS mouse model. Therefore, to further explore the regulatory effect of miR-155 on neointima formation in AS and locate potential anti-atherosclerosis target.METHODS:The mouse vascular aorta smooth muscle cell (MOVAS) was cultured and transfected with recombinant Pad2YFG adenovirus fluorescent vector with miR-155 fragment into 4 groups. Western blotting and RT-PCR were performed to identify the expression of NoxA1 under different circumstances. Fluorescence microscope was applied to observe the transfection rate of miR-155 into adenovirus. Twelve-week fatty food induced atherosclerotic ApoE-/- mouse model was established as host to accept miR-155 transfected adenovirus transplantation to observe its effect on VSMC in AS progression. Carotid and thoracic artery were extracted at 1 month after dosing. Distribution of miR-155 was quantified via expression levels of protein and RNA to detect NoxA1, Nox1, p47phox and NADPH expression. Immunohistochemistry, fluorescence imaging and other methods were performed in arteries section to compare the thickness of neointima and assess the severity of AS in each group.RESULTS:Luciferase reporter gene assay showed significant expression of miR-155 in mimic group indicating that miR-155 had target binding effect with NoxA1 gene. Western blotting and RT-PCR results both showed significantly decreased NoxA1 expression in miR-155 mimic group while increased with its inhibitor. The miR-155 distribution was observed varied at 1 month after in control, miR-155 mimic and inhibitor groups. The NoxA1, NADPH, Nox1 and pp47phox protein expression in VSMC was decreased in mimic group vs control and inhibitor groups (P<0.05); no significant difference of NADPH expression was observed in all groups. The NoxA1, Nox1 and p47phox gene expression in VSMC were both found reduced compared with those of control group at week 4 (P<0.05). Immunohistochemistry staining of artery frozen sections figured out that the thickness of neointima of carotid artery in miR-155 mimic group was significantly lower vs control and inhibitor groups (P<0.01) at week 4.CONCLUSIONS:miR-155 played an important role in NoxA1-related signaling pathway. miR-155 transfection into VSMC may have anti-inflammatory regulatory effect on NoxA1 expression in vivo and resulting in amelioration of atherosclerotic lesion in AS mouse model. In summary, miR-155 specifically plays in a negative feedback loop and demonstrates a protective role during atherosclerosis-associated VSMC proliferation and neointima formation through the miR-155-NoxA1-p47phox complex signaling pathway.

LncRNA MEG3-derived Mir-361-5p Regulate Vascular Smooth Muscle Cells Proliferation and Apoptosis by Targeting ABCA1.

Silencing of MEG3 inhibited ox‐LDL‐induced inflammation and apoptosis in macrophages via modulation of the MEG3/miR‐204/CDKN2A regulatory axis

Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21

Long Noncoding RNA MEG3 Mediated Angiogenesis after Cerebral Infarction Through Regulating P53/nox4 Axis.

Long non‐coding RNA AL355711 promotes smooth muscle cell migration through the ABCG1/MMP3 pathway

MiR-155 Acts As an Inhibitory Factor in Atherosclerosis-Associated Arterial Pathogenesis by Down-Regulating NoxA1 Related Signaling Pathway in ApoE-/- Mouse.

LncRNA MEG3: Potential stock for precision treatment of cardiovascular diseases

Inhibition of the Mir-193B-3p Protects Against Oxidized Low-Density Lipoprotein-Induced HUVECs Injury by Upregulating ALDH2.

LncRNA AC096664.3/PPAR‐γ/ABCG1‐dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis

MiR-506-3p Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells Via Targeting KLF4

Long Non-Coding RNA MEG8 Suppresses Hypoxia-Induced Excessive Proliferation, Migration and Inflammation of Vascular Smooth Muscle Cells by Regulation of the miR-195-5p/RECK Axis

Circ_0002984 Induces Proliferation, Migration and Inflammation Response of VSMCs Induced by Ox‐ldl Through Mir‑326‐3p/vamp3 Axis in Atherosclerosis

Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction

LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis.

MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A.

Mir-125A-5p Inhibits the Expression of NLRP3 by Targeting CCL4 in Human Vascular Smooth Muscle Cells Treated with Ox-Ldl

Retraction Note To: LncRNA HCG11 Regulates Proliferation and Apoptosis of Vascular Smooth Muscle Cell Through Targeting Mir‑144‑3p/foxf1 Axis in Atherosclerosis

LncRNA TNK2-AS1 Regulated Ox-Ldl-stimulated HASMC Proliferation and Migration Via Modulating VEGFA and FGF1 Expression by Sponging Mir-150-5p

Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells.

The multifaceted biology of lncR-Meg3 in cardio-cerebrovascular diseases

Mir-33A-5p Suppresses Ox-Ldl-stimulated Calcification of Vascular Smooth Muscle Cells by Targeting METTL3